Introduction {#sec1}
============

Aza and polyazaadamantanes continue to play important roles in organic and medicinal chemistry.^[@ref1]−[@ref13]^ Among the most useful members of the azaadamantane family are the azaadamantanones **1--4** ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}). 1-Azaadamantane-4-one (**2**), the first azaadamantanone isomer to be described,^[@ref14]^ was synthesized from amino ketal **5** in a double intramolecular Mannich reaction^[@ref15],[@ref16]^ ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}) and has figured prominently in diastereofacial selection studies.^[@ref17],[@ref18]^ More recently, the highly pyramidalized reactive lactam 1-azaadamantan-2-one (**1**) was obtained by the pyrolysis of *N*-Boc amino acid **6**.^[@ref19]^ Compound **7**, the benzamide derivative of 2-azaadamantan-4-one (**3**), the third isomer of this family, was synthesized from unsaturated bicyclic carboxylic acid **8** in seven steps in 31% overall yield.^[@ref20]^ Key steps in this synthesis were a Curtius rearrangement, leading to **9**, followed by epoxidation and spontaneous intramolecular attack of the amide nitrogen on the transient epoxide intermediate to form the alcohol precursor of **7**. As described in a 2018 patent,^[@ref21]^ compound **10**, the *N*-benzyl derivative of 2-azaadamantan-6-one (**4**) and fourth isomer of this family, was synthesized from bicyclo\[3.3.1\]nonane-3,7,9-trione mono ethylene ketal (**11**)^[@ref22]^ in four steps in 15% overall yield. The key step in this synthesis was a reductive amination to form azaadamantane **12**. In this work,^[@ref21]^ compounds were characterized only by low-resolution mass spectrometry data.

![1-Azaadamantan-2-one (**1**), 1-azaadamantan-4-one (**2**), 2-azaadamantan-4-one (**3**), and 2-azaadamantan-6-one (**4**).](ao-2018-01819p_0001){#fig1}

![Synthesis of **1**, **2**, the Benzamide (**7**) Derivative of **3**, and the *N*-Benzyl (**10**) Derivative of **4**](ao-2018-01819p_0003){#sch1}

We envisioned that a similar reaction sequence to that executed by Staas and Spurlock^[@ref20]^ in the synthesis of **7** ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}) with 9-oxo *endo*-bicyclo\[3.3.1\]non-6-ene-3-carboxylic acid (**13**) (vide infra) rather than **8** could provide an avenue to obtain **4**. Such an approach was recently exemplifed by Kozawa and Endo^[@ref23]^ and Shibuya et al.^[@ref24]^ who converted **8** to carbamate **14**([@ref24]) via a Curtius rearrangement, followed by bromine-mediated cyclization to **15** ([Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}). Hydrogenolysis of **15** yielded the desired 2-azaadamantane **16**. Although the presumed β-bromo azaadamantane reaction intermediate **17** was not isolated, the authors were able to characterize its tetracyclic aziridine cyclization product **18** which underwent hydrogenolysis to **16**.^[@ref23]^ More directly, Shibuya et al.^[@ref24]^ converted **14** to **16** in one step by intramolecular hydroamination with four equivalents of triflic acid.

![Synthesis of 2-Azaadamantane (**16**) by Two Different Reaction Pathways](ao-2018-01819p_0004){#sch2}

Results and Discussion {#sec2}
======================

Accordingly, we prepared starting material **13** in three steps from bicyclo\[3.3.1\]nonane-2,6-dione^[@ref25]^ in 55% overall yield according to a modified method of Stetter and Dorsch.^[@ref26]^ Conversion of **13** to carbamate **19** (83% yield) was readily achieved by a Curtius rearrangement, followed by reaction with benzyl alcohol using the reaction protocol described by Shibuya et al^[@ref24]^ ([Scheme [3](#sch3){ref-type="scheme"}](#sch3){ref-type="scheme"}). Several attempts using hydroamination reactions with triflic acid^[@ref20]^ or other conditions^[@ref27],[@ref28]^ failed to effect ring closure of **19** to the desired azaadamantane. However, exposure of **19** to either bromine at 0 °C or *N*-bromosuccinimide (NBS) at room temperature (rt) effected cyclization to bromo azaadamantane carbamate **20** in 97--99% yield. Treatment of **20** with H~2~, Pd/C, and K~2~CO~3~ in MeOH (or EtOH) effected a one-pot Cbz deprotection and debromination to afford the desired **4**, which due to its high water solubility was converted to Boc derivative **21** in an overall yield of 77%. Deprotection of **21** with ethereal hydrogen chloride afforded **4** as the hydrochloride salt in 94% yield ([Scheme [4](#sch4){ref-type="scheme"}](#sch4){ref-type="scheme"}). In addition, **23**, the ethylene ketal derivative of **4**, was obtained from **21** in a two-step sequence with an overall yield of 77%.

![Synthesis of **21**, the Boc Derivative of **4**](ao-2018-01819p_0005){#sch3}

![Synthesis of 2-Azaadamantan-6-one (**4**) and Its Ethylene Ketal Derivative **23**](ao-2018-01819p_0006){#sch4}

Next, in an attempt to convert **20** to key intermediate **21** in a one-pot reaction, we exposed **20** to H~2~, Pd/C, Boc~2~O, and Et~3~N in dioxane ([Scheme [5](#sch5){ref-type="scheme"}](#sch5){ref-type="scheme"}). Unexpectedly, this reaction formed **24**, the transcarbamylation product, not the desired **21**. Product **24** was also formed when using tetrahydrofuran (THF) as the solvent or K~2~CO~3~ as the base. As we had not observed **26** in the conversion of **20** to **4** via **21**, we recognized that **24** afforded another opportunity to synthesize **26**. Thus, deprotection of **24** with trifluoroacetic acid (TFA) afforded **25** as the trifluoroacetate salt in 92% yield. Treatment of **25** with K~2~CO~3~ in MeOH effected cyclization to **26**. Hydrogenation of the crude reaction product afforded **4**. However, the instability of **26** precluded its isolation, and we could only characterize it by extraction with CDCl~3~, followed by NMR and high-resolution mass spectrometry (HRMS) analysis.

![Synthesis of Tetracyclic Keto Aziridine **26**](ao-2018-01819p_0007){#sch5}

The structure of **26** was strongly suggested by 10 signals in the ^13^C{^1^H} NMR spectrum including a downfield signal at 212.8 ppm, three methylene carbons in the APT spectrum, and a molecular formula of C~9~H~11~NO determined by HRMS. This structural assignment was consistent with key COSY correlations, which identified H-9 as the only methine hydrogen with vicinal coupling to its hydrogen partners on the adjacent methine carbons C-3 and C-7. Further, a 15N--1H heteronuclear multiple bond correlation experiment showed that 2-N is a tertiary amine by the chemical shift and absence of a directly bonded hydrogen; these data also revealed two-bond correlations between 2-N and the hydrogen atoms on methine carbons C-1 and C-9 and three-bond correlations between 2-N and the hydrogen atoms on methylene carbons C-4, C-8, and C-10.

The debromination of both **16** and **20** in MeOH and EtOH solvents during hydrogenolysis presumably occurs via S~N~2 cyclization to form an aziridinium bromide intermediate, which after formation of the free base undergoes further hydrogenolysis opening the aziridine ring. Because loss of bromide was not observed in aprotic dioxane and THF solvents, we modeled the intramolecular S~N~2 reaction to better understand the effects of solvent and the carbonyl substituent. [Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"} shows the potential energy diagram for the intramolecular conversion of **17** and **25** to their respective aziridinium salts **18**H^+^ and **26**H^+^. Using the M06-2x functional of Zhao and Truhlar,^[@ref29]^ transition-state structures were located and used as inputs for intrinsic reaction coordinate calculations. The following results are of interest: (1) both the free energy of activation and the free energy of the reaction are lower for **17** versus **25**; (2) the less than ideal angle of S~N~2 attack of 152.8° is the same for both nonketone and ketone azaadamantane transition states; (3) base neutralization of **26**H^+^ is more exergonic compared to that of **18**H^+^ (modeled with sodium carbonate base); and (4) changing to a less polar THF solvent increases both the free energy of activation and endergonic value of the reaction.

![Potential energy diagram for the intramolecular conversion of **17** and **25** to their respective aziridinium salts **18**H^+^ and **26**H^+^.](ao-2018-01819p_0002){#fig2}

From these data, we surmise that decrease in stability of the aziridinium product by the presence of an electron-withdrawing ketone or a decrease in solvent polarity makes aziridinium ion formation less favorable. These results also imply that the initial basicity of the azaadamantane is the key factor in the formation of the aziridine intermediate; the more basic the azadamantane, the more favorable the S~N~2 cyclization. Isodesmic modeling of proton affinity differences between **17** and **25** indicates that **17** is approximately four p*K*~a~ units more basic than **25** ([Supporting Information](http://pubs.acs.org/doi/suppl/10.1021/acsomega.8b01819/suppl_file/ao8b01819_si_001.pdf)). The substantial decrease in basicity afforded by a carbonyl group three bonds from the aza group is consistent with the withdrawal of electron density by both inductive and field effects.^[@ref30]^

Encouraged by the successful conversion of **13** to **4**, we then sought to use a similar approach to convert **8** to **3** ([Scheme [6](#sch6){ref-type="scheme"}](#sch6){ref-type="scheme"}). The starting material bicyclic carbamate **14** was obtained from **8** according to the method of Shibuya et al.^[@ref24]^ Treatment of **14** with *meta*-chloroperoxybenzoic acid (*m*-CPBA) effected cyclization to hydroxy azaadamantane carbamate **27** in 81% yield; **27** was presumably formed as the anti epimer^[@ref20]^ assuming back-side attack of the epoxide by the carbamate. Oxidation of **27** furnished **28**, the Cbz derivative of **3** in 93% yield. Transcarbamylation of **28** afforded the corresponding Boc derivative **29** in 98% yield. However, all attempts to synthesize **3** by hydrogenolysis of **28** or acid-promoted deprotection of **29** failed. Nevertheless, we were able to convert **28** to **31**, the ethylene ketal derivative of **3**, in a three-step two-pot sequence with an overall yield of 96%. Thus, **3**, unlike **4**, is stable only when one of its two functional groups is in a protected form.

![Synthesis of the Cbz (**28**), Boc (**29**), and Ethylene Ketal (**31**) Derivatives of 2-Azaadamantan-4-one (**3**)](ao-2018-01819p_0008){#sch6}

In summary, we synthesized 2-azaadamantan-6-one (**4**) and its Boc (**21**) and ethylene ketal (**26**) derivatives. We also describe syntheses of the Cbz (**28**), Boc (**29**), and ethylene ketal (**31**) derivatives of 2-azaadamantan-4-one (**3**). We anticipate that these azaadamantanes will be useful starting points for further exploration because of the rich chemistry available for their ketone and secondary aliphatic amine functional groups.

Experimental Section {#sec3}
====================

General {#sec3.1}
-------

Melting points are uncorrected. 1D ^1^H and ^13^C NMR spectra were generated with a 500 MHz spectrometer using CDCl~3~ and DMSO-*d*~6~ as solvents. Chemical shifts are reported in parts per million (ppm) and are relative to internal (CH~3~)~4~Si (0 ppm) for ^1^H and CDCl~3~ (77.0 ppm) or DMSO-*d*~6~ (39.7 ppm) for ^13^C NMR. Electron ionization gas chromatography--MS (EI GC--MS) data were obtained using a quadrapole mass spectrometer with 30 m DB-5 type columns and a He flow rate of 1 mL/min. We used a silica gel (sg) particle size of 40--63 μm for all flash column chromatography. Reported reaction temperatures are those of the oil bath.

### 2-Azaadamantan-6-one Hydrochloride (**4**) {#sec3.1.1}

A mixture of **21** (200 mg, 0.80 mmol) and a 1 M HCl solution in diethyl ether (5 mL) was stirred at rt for 12 h. The resulting solid was filtered and washed with diethyl ether to afford **4** (141 mg, 94%) as a white solid. mp \> 350 °C (dec.). ^1^H NMR (DMSO-*d*~6~): δ 2.03--2.14 (m, 4H), 2.38--2.47 (m, 4H), 2.55 (d, *J* = 3.9 Hz, 2H), 3.69 (s, 2H), 9.69 (s, 2H); ^13^C NMR (DMSO-*d*~6~): δ 34.3, 43.2, 46.0, 212.6. Anal. Calcd for C~9~H~13~NO·HCl: C, 57.60; H, 7.52; N, 7.46. Found: C, 58.00; H, 7.50; N, 7.46.

### Benzyl(9-oxobicyclo\[3.3.1\]non-6-en-3-yl)carbamate (**19**) {#sec3.1.2}

To a mixture of 9-oxobicyclo\[3.3.1\]non-6-ene-3-carboxylic acid (**13**)^[@ref26]^ (8.00 g, 44.4 mmol), toluene (75 mL), and THF (15 mL), Et~3~N (11.23 g, 111.0 mmol) and diphenylphosphoryl azide (12.83 g, 46.6 mmol) were added at rt. The resulting mixture was stirred at rt for 3 h before addition of BnOH (19.20 g, 173.2 mmol); stirring continued under reflux for another 2 h. The solvents were removed in vacuo to give a colorless oil which was partitioned between EtOAc (200 mL) and H~2~O (100 mL). The organic layer was separated and washed with brine (100 mL), dried over anhydrous MgSO~4~, and concentrated. The crude was purified by column chromatography (sg, hexanes/EtOAc, 5:1--2:1) to give **19** (10.47 g, 83%) as a colorless oil. ^1^H NMR (CDCl~3~): δ 2.13--2.43 (m, 4H), 2.60--2.75 (m, 2H), 2.76--2.91 (m, 2H), 4.04--4.11 (m, 1H), 5.02--5.10 (m, 2H), 5.81--6.03 (m, 3H), 7.29--7.44 (m, 5H); ^13^C NMR (CDCl~3~): δ 37.1, 38.5, 40.9, 43.7, 43.8, 45.6, 66.7, 128.2, 128.6, 128.9, 131.2, 136.5, 155.4, 215.0. HRMS (ESI-TOF) *m*/*z*: \[M\]^+^ calcd for C~17~H~19~NO~3~, 285.1365; found, 285.1354.

### Benzyl 4-Bromo-6-oxo-2-azaadamantane-2-carboxylate (**20**) {#sec3.1.3}

#### Method 1 {#sec3.1.3.1}

To a mixture of **19** (5.71 g, 20.0 mmol) and K~2~CO~3~ (5.53 g, 40.0 mmol) in CH~3~CN (20 mL) at 0 °C was added dropwise a solution of bromine (4.79 g, 30.0 mmol) in CH~3~CN (6 mL). The resulting mixture was stirred for 30 min at 0 °C and then partitioned between EtOAc (100 mL) and H~2~O (50 mL). The organic layer was separated and washed with 1 N NaOH (30 mL) and brine (30 mL), dried over anhydrous MgSO~4~, and concentrated to afford **20** (7.21 g, 99%) as a white solid. mp 96--97 °C. ^1^H NMR (CDCl~3~): δ 2.03 (t, *J* = 15.0 Hz, 1H), 2.07--2.17 (m, 2H), 2.22 (t, *J* = 12.9 Hz, 1H), 2.35 (dd, *J* = 25.9, 13.4 Hz, 1H), 2.72 (d, *J* = 3.3 Hz, 1H), 2.80 (t, *J* = 15.4 Hz, 1H), 2.99 (s, 1H), 4.48 (s, 0.5H), 4.55 (s, 1H), 4.57 (s, 0.5H), 4.60 (s, 0.5H), 4.65 (s, 0.5H), 5.14--5.26 (m, 2H), 7.27--7.41 (m, 5H); ^13^C NMR (CDCl~3~): δ 31.7, 31.9, 37.5, 37.7, 39.8, 40.2, 44.1, 44.8, 45.5, 50.5, 51.2, 53.2, 53.7, 54.1, 67.7, 128.1, 128.4, 128.7, 136.2, 154.2, 154.3, 210.8. HRMS (ESI-TOF) *m*/*z*: \[M\]^+^ calcd for C~17~H~18~^79^BrNO~3~, 363.0470; found, 363.0483.

#### Method 2 {#sec3.1.3.2}

To a solution of **19** (285 mg, 1.0 mmol) in CH~2~Cl~2~ (5 mL) was added NBS (214 mg, 1.2 mmol) in one portion at rt. The resulting mixture was stirred at rt for 12 h and then quenched with H~2~O (5 mL). The organic layer was separated and washed with 1 N NaOH (5 mL) and brine (5 mL), dried over anhydrous MgSO~4~, and concentrated to afford **20** (353 mg, 97%) as a white solid.

### *tert*-Butyl 6-Oxo-2-azaadamantane-2-carboxylate (**21**) {#sec3.1.4}

#### Step 1 {#sec3.1.4.1}

A mixture of **20** (1.21 g, 3.32 mmol), K~2~CO~3~ (2.29 g, 16.6 mmol), and Pd--C (10 wt %) (0.12 g) in MeOH (50 mL) was stirred under H~2~ at rt. The reaction was traced by GC and NMR until peaks for **20**, and the intermediate keto aziridine **24** disappeared. After 16 h, the reaction mixture was filtered through Celite and washed with MeOH (20 mL). The filtrate was concentrated to afford an off-white residue composed of crude 2-azaadamantan-6-one (**4**) and inorganic salts, which was used as the starting material for the next step without further purification. ^1^H NMR (CDCl~3~): δ 2.05 (d, *J* = 12.3 Hz, 4H), 2.28 (d, *J* = 11.3 Hz, 4H), 2.71 (s, 2H), 3.26 (s, 2H); ^13^C NMR (CDCl~3~): δ 39.5, 45.9, 46.4, 217.4.

#### Step 2 {#sec3.1.4.2}

To a mixture of the crude **4**, NaHCO~3~ (418 mg, 4.98 mmol), dioxane (30 mL), and H~2~O (10 mL) was added dropwise a solution of (Boc)~2~O (869 mg, 3.98 mmol) in dioxane (10 mL) at rt. The resulting mixture was stirred at rt overnight and concentrated. The resultant residue was partitioned between EtOAc (30 mL) and H~2~O (20 mL). The organic layer was separated and washed with brine, dried over anhydrous MgSO~4~, and concentrated. The crude was purified by column chromatography (sg, hexane/EtOAc, 5:1--2:1) to give **21** (640 mg, 77%) as a white solid. mp 126--127 °C. ^1^H NMR (CDCl~3~): δ 1.50 (s, 9H), 2.01 (t, *J* = 10.1 Hz, 4H), 2.18 (t, *J* = 13.2 Hz, 4H), 2.69 (s, 2H), 4.34 (s, 1H), 4.47 (s, 1H); ^13^C NMR (CDCl~3~): δ 28.4, 37.5, 37.8, 45.0, 46.4, 79.8, 154.1, 215.9. HRMS (ESI-TOF) *m*/*z*: \[M\]^+^ calcd for C~14~H~21~NO~3~, 251.1521; found, 251.1525. Anal. Calcd for C~14~H~21~NO~3~: C, 66.91; H, 8.42; N, 5.57. Found: C, 67.08; H, 8.43; N, 5.67.

### 6-Azaspiro\[adamantane-2,2′-\[1,3\]dioxolane\] Hydrochloride (**23**) {#sec3.1.5}

#### Step 1 {#sec3.1.5.1}

A mixture of **21** (251 mg, 1 mmol), ethylene glycol (124 mg, 2 mmol) *p*-toluenesulfonic acid (20 mg), and toluene (10 mL) was heated under reflux for 12 h in a Dean--Stark apparatus. After cooling, the reaction mixture was washed with saturated NaHCO~3~ (10 mL) and brine (10 mL), dried over anhydrous MgSO~4~, and concentrated. The crude product was purified by column chromatography (sg, hexane/EtOAc, 5:1) to afford *tert*-butyl 6-azaspiro\[adamantane-2,2′-\[1,3\]dioxolane\]-6-carboxylate (**22**) (131 mg, 100%) as a white solid. mp 92--93 °C ^1^H NMR (CDCl~3~): δ 1.45 (d, *J* = 2.8 Hz, 9H), 1.71--1.82 (m, 4H), 1.92 (d, *J* = 10.9 Hz, 6H), 3.96 (s, 4H), 4.10 (s, 1H), 4.23 (s, 1H); ^13^C NMR (CDCl~3~): δ 28.5, 33.3, 33.6, 35.1, 44.8, 46.3, 64.41, 64.43, 79.1, 110.1, 154.3.

#### Step 2 {#sec3.1.5.2}

A mixture of **22** (100 mg, 0.34 mmol) and 1 M ethereal HCl (3 mL) was stirred at rt for 12 h. The resulting solid was filtered and washed with diethyl ether to afford **23** (56 mg, 77%) as a white solid. mp 337--338 °C. ^1^H NMR (DMSO-*d*~6~): δ 1.92 (d, *J* = 11.6 Hz, 6H), 2.02--2.15 (m, 4H), 3.47 (s, 2H), 3.92 (s, 4H), 9.28 (s, 2H); ^13^C NMR (DMSO-*d*~6~): δ 30.8, 33.5, 45.8, 64.7, 108.4. Anal. Calcd for C~11~H~17~NO~2~·HCl: C, 57.02; H, 7.83; N, 6.04. Found: C, 57.42; H, 7.66; N, 6.04.

### *tert*-Butyl 4-Bromo-6-oxo-2-azaadamantane-2-carboxylate (**24**) {#sec3.1.6}

A mixture of **20** (365 mg, 1.00 mmol), di-*tert*-butyl dicarbonate (262 mg, 1.20 mmol), and triethylamine (202 mg, 2 mmol) in dioxane (10 mL) was stirred under H~2~ at rt for 12 h and then filtered. The filtrate was concentrated and redissolved in EtOAc (50 mL), washed with 1 N HCl (10 mL), saturated NaHCO~3~ (10 mL), and brine (10 mL), dried over anhydrous MgSO~4~, and then concentrated. The crude reaction product was purified by column chromatography (sg, hexane/EtOAc, 5:1) to afford **24** (290 mg, 88%) as a white solid. mp 76--77 °C. ^1^H NMR (CDCl~3~): δ 1.49 (s, 9H), 2.00 (t, *J* = 10.5 Hz, 1H), 2.10 (t, *J* = 12.8 Hz, 1H), 2.14--2.24 (m, 1H), 2.33 (dt, *J* = 15.7, 8.1 Hz, 1H), 2.70 (s, 1H), 2.76 (t, *J* = 11.9 Hz, 1H), 2.98 (s, 1H), 4.35 (s, 0.5H), 4.41 (s, 0.5H), 4.48 (s, 0.5H), 4.57 (s, 0.5H), 4.58 (s, 1H); ^13^C NMR (CDCl~3~): δ 28.3, 31.6, 31.8, 37.5, 37.7, 39.9, 40.3, 44.0, 44.2, 45.5, 49.8, 51.4, 53.3, 54.1, 54.4, 80.8, 80.9, 153.7, 211.2. HRMS (ESI-TOF) *m*/*z*: \[M\]^+^ calcd for C~14~H~20~^79^BrNO~3~, 329.0627; found, 329.0620.

### 4-Bromo-6-oxo-2-Azaadamantane Trifluoroacetate (**25**) {#sec3.1.7}

A mixture of **24** (220 mg, 0.67 mmol), TFA (1 mL), and CH~2~Cl~2~ (5 mL) was stirred at rt for 24 h and then concentrated in vacuo at rt. The residue was mixed with diethyl ether (10 mL) and stirred for 30 min. The precipitate was collected by filtration and washed with diethyl ether (2 mL) to afford **25** (212 mg, 92%) as a white solid. mp 138--139 °C. ^1^H NMR (CDCl~3~): δ 2.17 (d, *J* = 14.1 Hz, 1H), 2.29 (d, *J* = 14.4 Hz, 1H), 2.58 (d, *J* = 14.6 Hz, 1H), 2.67 (d, *J* = 14.3 Hz, 1H), 2.80 (d, *J* = 12.9 Hz, 2H), 2.90 (d, *J* = 14.6 Hz, 1H), 3.08 (s, 1H), 3.81 (s, 1H), 3.88 (s, 1H), 5.00 (s, 1H), 10.50 (brs, 2H); ^13^C NMR (CDCl~3~): δ 29.7, 35.0, 36.1, 42.4, 45.7, 48.5, 50.7, 51.2, 206.9. Anal. Calcd for C~9~H~12~BrNO·C~2~HF~3~O~2~: C, 38.39; H, 3.81; N, 4.07. Found: C, 38.50; H, 3.91; N, 3.98.

### Octahydro-2,4-methanoazirino\[2,1,3-*cd*\]indolizin-7-one (**26**) {#sec3.1.8}

A mixture of **25** (50 mg, 0.15 mmol) and K~2~CO~3~ (60 mg, 0.44 mmol) in MeOH (5 mL) was stirred at rt for 2 h and filtered. The filtrate was concentrated in vacuo at rt to remove most of the solvent. The residue was then extracted with chloroform. The extract was concentrated in vacuo at rt and redissolved in CDCl~3~. The concentration--redissolution step was repeated three times to remove the residual MeOH. ^1^H NMR (CDCl~3~): δ 1.80 (ddt, *J* = 13.3, 4.3, 1.9 Hz, 1H), 2.01 (dtd, *J* = 13.1, 3.7, 1.5 Hz, 1H), 2.18 (dd, *J* = 11.3, 2.2 Hz, 1H), 2.43 (dtt, *J* = 4.7, 3.1, 1.5 Hz, 1H), 2.51 (dq, *J* = 14.7, 2.5 Hz, 1H), 2.55--2.63 (m, 2H), 2.84 (td, *J* = 4.6, 1.6 Hz, 1H), 2.90--3.05 (m, 2H), 3.78 (t, *J* = 4.6 Hz, 1H); ^13^C NMR (CDCl~3~): δ 32.3, 36.0, 41.9, 42.3, 47.7, 48.5, 52.0, 54.1, 212.7. HRMS (ESI-TOF) *m*/*z*: \[M\]^+^ calcd for C~9~H~11~NO, 149.0841; found, 149.0841.

### Benzyl 4-Hydroxy-2-azaadamantane-2-carboxylate (**27**) {#sec3.1.9}

To a mixture of *m*-CPBA (2.54 g, 14.74 mmol) and CH~2~Cl~2~ (25 mL) was added dropwise a solution of benzyl(bicyclo\[3.3.1\]non-6-en-3-yl)carbamate (**14**)^[@ref24]^ (2.00 g, 7.37 mmol). The resulting mixture was stirred at rt for 12 h, washed with 1 N NaOH (20 mL) and brine (20 mL), dried over anhydrous MgSO~4~, and then concentrated. The crude product was purified by column chromatography (sg, CH~2~Cl~2~/CH~3~OH, 5:1) to afford **27** (1.72 g, 81%) as a colorless oil. ^1^H NMR (CDCl~3~): δ 1.50--1.74 (m, 3H), 1.82 (dt, *J* = 19.4, 3.3 Hz, 3H), 1.90--1.98 (m, 1H), 1.98--2.05 (m, 1H), 2.05--2.23 (m, 3H), 3.86 (dt, *J* = 7.4, 3.5 Hz, 1H), 4.20 (s, 0.5H), 4.25 (s, 0.5H), 4.26 (s, 0.5H), 4.32 (s, 0.5H), 5.13 (d, *J* = 12.5 Hz, 2H), 7.27--7.43 (m, 5H); ^13^C NMR (CDCl~3~): δ 25.8, 28.7, 29.0, 29.31, 29.34, 32.8, 33.1, 34.8, 35.3, 35.5, 45.8, 46.4, 51.0, 51.3, 66.9, 67.0, 70.2, 70.6, 127.7, 127.8, 127.9, 128.5, 136.9, 154.7, 154.9. HRMS (ESI-TOF) *m*/*z*: \[M\]^+^ calcd for C~17~H~21~NO~3~, 287.1521; found, 287.1519.

### Benzyl 4-Oxo-2-azaadamantane-2-carboxylate (**28**) {#sec3.1.10}

To a mixture of pyridinium chlorochromate (2.51 g, 11.62 mmol) and CH~2~Cl~2~ (20 mL) was added dropwise a solution of **24** (1.67 g, 5.81 mmol) in CH~2~Cl~2~ (10 mL). The resulting mixture was stirred at rt for 2 h and filtered. The filter cake was washed with CH~2~Cl~2~ (10 mL). The combined filtrate was washed with 1 N HCl (20 mL) and brine (20 mL), dried over anhydrous MgSO~4~, and concentrated. The crude product was purified by column chromatography (sg, hexane/EtOAc, 4:1) to afford **28** (1.56 g, 93%) as a colorless oil. ^1^H NMR (CDCl~3~): δ 1.81--1.95 (m, 2H), 1.95--2.12 (m, 3H), 2.12--2.28 (m, 4H), 2.68 (s, 1H), 4.44 (s, 0.5H), 4.49 (s, 0.5H), 4.55 (s, 0.5H), 4.62 (s, 0.5H), 5.04--5.20 (m, 2H), 7.23--7.39 (m, 5H); ^13^C NMR (CDCl~3~): δ 26.1, 34.1, 34.3, 37.4, 37.6, 38.1, 45.5, 46.0, 46.6, 60.4, 67.3, 127.8, 128.0, 128.5, 136.5, 154.3, 209.9, 210.2. HRMS (ESI-TOF) *m*/*z*: \[M\]^+^ calcd for C~17~H~19~NO~3~, 285.1365; found, 285.1360.

### *tert*-Butyl 4-Oxo-2-azaadamantane-2-carboxylate (**29**) {#sec3.1.11}

A mixture of **28** (1.43 g, 5.00 mmol), di-*tert*-butyl dicarbonate (1.64 g, 7.50 mmol), Pd--C (10 wt %) (0.14 g), and K~2~CO~3~ (1.38 g, 10 mmol) in EtOH (30 mL) was stirred under H~2~ at rt for 12 h and then filtered. The filtrate was concentrated and redissolved in EtOAc (50 mL), washed with 1 N HCl (10 mL), saturated NaHCO~3~ (10 mL), and brine (10 mL), dried over anhydrous MgSO~4~, and then concentrated. The crude product was purified by column chromatography (sg, hexane/EtOAc, 4:1) to afford **29** (1.24 g, 98%) as a colorless oil. ^1^H NMR (CDCl~3~): δ 1.45 (s, 9H), 1.90 (d, *J* = 12.7 Hz, 2H), 1.95--2.12 (m, 3H), 2.18 (d, *J* = 11.6 Hz, 4H), 2.68 (s, 1H), 4.52 (s, 0.5H), 4.39 (s, 0.5H), 4.38 (s, 0.5H), 4.52 (s, 0.5H); ^13^C NMR (CDCl~3~): δ 26.1, 28.3, 34.1, 37.5, 38.2, 45.2, 45.5, 46.7, 59.2, 60.7, 80.2, 153.8, 210.9. HRMS (ESI-TOF) *m*/*z*: \[M\]^+^ calcd for C~14~H~21~NO~3~, 251.1521; found, 251.1530.

### Benzyl 4-Azaspiro\[adamantane-2,2′-\[1,3\]dioxolane\]-4-carboxylate (**30**) {#sec3.1.12}

A mixture of **28** (1.14 g, 4 mmol), ethylene glycol (0.26 g, 8 mmol), *p*-toluenesulfonic acid (30 mg), and toluene (30 mL) was heated under reflux for 4 h in a Dean--Stark apparatus. After cooling to rt, the reaction mixture was washed with saturated NaHCO~3~ (10 mL) and brine (10 mL), dried over anhydrous MgSO~4~, and concentrated to afford **30** (1.31 g, 100%) as a colorless oil. ^1^H NMR (CDCl~3~): δ 1.59--1.72 (m, 2H), 1.72--1.85 (m, 3H), 1.93--2.10 (m, 4H), 2.20 (ddt, *J* = 16.0, 13.2, 3.1 Hz, 1H), 3.71--4.09 (m, 4.5H), 4.22 (s, 0.5H), 4.26 (s, 0.5H), 4.31 (0.5H), 4.99--5.35 (m, 2H), 7.32--7.40 (m, 5H); ^13^C NMR (CDCl~3~): δ 25.2, 25.2, 32.2, 32.3, 33.1, 33.3, 33.6, 34.8, 35.1, 36.03, 36.04, 45.7, 46.2, 51.5, 52.3, 64.3, 64.5, 65.0, 66.8, 66.8, 107.5, 127.6, 127.8, 128.4, 137.2, 155.2, 155.3. HRMS (ESI-TOF) *m*/*z*: \[M\]^+^ calcd for C~19~H~23~NO~4~, 329.1627; found, 329.1611.

### 4-Azaspiro\[adamantane-2,2′-\[1,3\]dioxolane\] Hydrochloride (**31**) {#sec3.1.13}

#### Step 1 {#sec3.1.13.1}

A mixture of **30** (500 mg, 1.52 mmol) and Pd--C (10 wt %) (25 mg) in EtOH (10 mL) was stirred under H~2~ at rt for 12 h and then filtered. The filtrate was concentrated to afford 4-azaspiro\[adamantane-2,2′-\[1,3\]dioxolane\] (292 mg, 99%) as light yellow oil. ^1^H NMR (CDCl~3~): δ 1.66 (dt, *J* = 13.0, 3.6 Hz, 1H), 1.74--1.81 (m, 2H), 1.88--1.97 (m, 5H), 2.00 (dq, *J* = 12.8, 2.8 Hz, 1H), 2.16 (dt, *J* = 12.8, 3.2 Hz, 1H), 2.56 (br s, 1H), 2.78 (q, *J* = 2.8 Hz, 1H), 3.00 (s, 1H), 3.91--4.04 (m, 4H); ^13^C NMR (CDCl~3~): δ 25.8, 33.1, 34.1, 35.8, 36.2, 36.7, 45.9, 53.2, 64.2, 64.9, 108.6.

#### Step 2 {#sec3.1.13.2}

To a stirred solution of 4-azaspiro\[adamantane-2,2′-\[1,3\]dioxolane\] (100 mg, 0.51 mmol) in diethyl ether (5 mL) was added dropwise 1 N HCl in diethyl ether (1 mL). The resulting mixture was stirred at rt for 10 min and then filtered. The solid was washed with diethyl ether (2 mL) and dried in vacuo to afford **31** (115 mg, 97%) as an off-white solid. mp 266--267 °C. ^1^H NMR (DMSO-*d*~6~): δ 1.71--1.83 (m, 2H), 1.82--1.96 (m, 5H), 2.02--2.20 (m, 3H), 3.42 (s, 2H), 3.88--4.06 (m, 4H), 8.44 (s, 1H), 9.81 (s, 1H); ^13^C NMR (DMSO-*d*~6~): δ 23.6, 30.0, 30.9, 31.9, 32.3, 34.7, 46.3, 51.5, 64.9, 65.4, 105.5. Anal. Calcd for C~11~H~17~NO~2~·HCl: C, 57.02; H, 7.83; N, 6.04. Found: C, 56.86; H, 7.64; N, 5.85.

The Supporting Information is available free of charge on the [ACS Publications website](http://pubs.acs.org) at DOI: [10.1021/acsomega.8b01819](http://pubs.acs.org/doi/abs/10.1021/acsomega.8b01819).^1^H and ^13^C{^1^H} NMR spectra (500 MHz) of **4** and **19--31** and 2D NMR (600 MHz) spectra of **26**, Gaussian output energies and data tables, isodesmic calculations, and Gaussian input file examples ([PDF](http://pubs.acs.org/doi/suppl/10.1021/acsomega.8b01819/suppl_file/ao8b01819_si_001.pdf))
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